Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial.

Gentry, L O; Ramirez-Ronda, C H; Rodriguez-Noriega, E; Thadepalli, H; del Rosal, P L; Ramirez, C

Gentry, L O; Ramirez-Ronda, C H; Rodriguez-Noriega, E; Thadepalli, H; del Rosal, P L; Ramirez, C.

Affiliation

Gentry LO; St Luke's Episcopal Hospital, Houston, TX 77030.

Arch Intern Med ; 149(11): 2579-83, 1989 Nov.

Article in En | MEDLINE | ID: mdl-2684078

Subject(s)

Bacterial Infections/drug therapy; Cefotaxime/administration & dosage; Ciprofloxacin/administration & dosage; Skin Diseases, Infectious/drug therapy; Wound Infection/drug therapy; Administration, Oral; Cefotaxime/therapeutic use; Ciprofloxacin/therapeutic use; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Skin Diseases, Infectious / Bacterial Infections / Wound Infection / Ciprofloxacin / Cefotaxime Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Year: 1989 Type: Article

Search on Google

XML

PubMed Links